This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Contributors
  • Su Young

Su Young


Consultant Ophthalmic Surgeon


Tennent Institute of Ophthalmology, NHS Greater Glasgow and Clyde, UK.

Latest Contribution


Transcanalicular diode laser-assisted DCR: success rates and factors for success

1 December 2021 | Su Young | EYE - Oculoplastic, EYE - Orbit

This study aimed to evaluate the success rates of transcanalicular diode laser-assisted dacryocystorhinostomy (TCL-DCR) during three years of follow-up and to find clinical factors that influence surgical outcomes. Major outcomes were defined as a patent neo-ostium tested by irrigation (anatomical...


Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections

1 December 2021 | Su Young | EYE - Vitreo-Retinal | IVI, In-house compounded, bevacizumab, compounding pharmacy, endophthalmitis

This multicentre study examining a five-year period from 2014 to 2018 evaluated the incidence rate and outcomes of endophthalmitis after intravitreal injection of in-house compounded bevacizumab. In-house compounded syringes were prepared in compounding pharmacy using sterile standard operating guidelines. All...


OCT biomarkers in asymmetric anti-VEGF response in bilateral diabetic macular oedema

1 December 2021 | Su Young | EYE - Vitreo-Retinal | Diabetic macular edema, aflibercept, optical coherence tomography, predictive, ranibizumab

This study aimed to identify optical coherence tomography (OCT) biomarkers for predicting response to anti-VEGF treatment in diabetic macular oedema (DMO). Bilateral DMO patients with asymmetric response to a loading dose of anti-VEGF (ranibizumab / aflibercept) treatment were retrospectively studied....


  • «
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • »
People
A-Z Filter
ABCDEFGHIJKLMNOPQRSTUVWXYZ
View all people

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency